Use of ferumoxides for stem cell labeling

Regenerative Medicine

Volumn 3, Issue 6, 2008, Pages 807-816

  Sadek, Hesham ^a   Latif, Shuaib ^a   Collins, Robert ^a   Garry, Mary G ^a   Garry, Daniel J ^a,b,c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Cardiomyocytes; Cell transfer therapies; Ferumoxides; Heart; Human stem cells; Stem cells

Indexed keywords

PROTAMINE SULFATE; SUPERPARAMAGNETIC IRON OXIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL LABELING; CELL POPULATION; CELL PROLIFERATION; CELL SEPARATION; CELL VIABILITY; CONTROLLED STUDY; HEART MUSCLE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; IN VIVO STUDY; MONONUCLEAR CELL; MYOBLAST; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RAT; SENSITIVITY ANALYSIS; STEM CELL TRANSPLANTATION; TISSUE REGENERATION;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; CELL LINEAGE; CELL PROLIFERATION; CELL SEPARATION; CELL SURVIVAL; FLOW CYTOMETRY; HUMANS; IRON; LEUKOCYTES, MONONUCLEAR; MAGNETICS; MICE; MYOCYTES, CARDIAC; OXIDES; PROTAMINES; RATS; STAINING AND LABELING; STEM CELLS; VENTRICULAR FUNCTION, LEFT;

EID: 58149119399     PISSN: 17460751     EISSN: None     Source Type: Journal    
DOI: 10.2217/17460751.3.6.807     Document Type: Article

References (42)

1. Nygren JM, Jovinge S, Breitbach M et al.: Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat. Med. 10, 494-501 (2004).
2. Balsam LB, Wagers AJ, Christensen JL, Kofidis T, Weissman IL, Robbins RC: Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 428, 668-673 (2004).
3. Jackson KA, Majka SM, Wang H et al.: Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J. Clin. Invest. 107, 1395-1402 (2001).
4. Orlic D, Kajstura J, Chimenti S et al.: Bone marrow cells regenerate infarcted myocardium. Nature 410, 701-705 (2001).
5. Orlic D, Kajstura J, Chimenti S, Bodine DM, Leri A, Anversa P: Transplanted adult bone marrow cells repair myocardial infarcts in mice. Ann. NY Acad. Sci. 938, 221-229; discussion 229-230 (2001).
6. Murry CE, Soonpaa MH, Reinecke H et al.: Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428, 664-668 (2004).
7. Urbanek K, Quaini F, Tasca G et al.: Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy. Proc. Natl Acad. Sci. USA 100, 10440-10445 (2003).
8. Dawn B, Stein AB, Urbanek K et al.: Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function. Proc. Natl Acad. Sci. USA 102, 3766-3771 (2005).
9. +-enriched cell population into cardiomyocytes, endothelial cells, and smooth muscle cells in vivo. Circulation 108, 2070-2073 (2003).
10. Assmus B, Fischer-Rasokat U, Honold J et al.: Transcoronary transplantation of functionally competent BMCs is associated with a decrease in natriuretic peptide serum levels and improved survival of patients with chronic postinfarction heart failure: results of the TOPCARE-CHD Registry. Circ. Res. 100, 1234-1241 (2007).
11. Schachinger V, Assmus B, Britten MB et al.: Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. J. Am. Coll. Cardiol. 44, 1690-1699 (2004).
12. Lunde K, Solheim S, Aakhus S et al.: Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N. Engl. J. Med. 355, 1199-1209 (2006).
13. Schachinger V, Erbs S, Elsasser A et al.: Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N. Engl. J. Med. 355, 1210-1221 (2006).
14. Assmus B, Honold J, Schachinger V et al.: Transcoronary transplantation of progenitor cells after myocardial infarction. N. Engl. J. Med. 355, 1222-1232 (2006).
15. Beeres SL, Bengel FM, Bartunek J et al.: Role of imaging in cardiac stem cell therapy. J. Am. Coll. Cardiol. 49, 1137-1148 (2007).
16. Walczak P, Kedziorek DA, Gilad AA, Barnett BP, Bulte JW: Applicability and limitations of MR tracking of neural stem cells with asymmetric cell division and rapid turnover: the case of the shiverer dysmyelinated mouse brain. Magn. Reson. Med. 58, 261-269 (2007).
17. Arbab AS, Yocum GT, Kalish H et al.: Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. Blood 104, 1217-1223 (2004).
18. Arbab AS, Yocum GT, Rad AM et al.: Labeling of cells with ferumoxides-protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoietic or mesenchymal stem cells. NMR Biomed. 18, 553-559 (2005).
19. Anderson SA, Glod J, Arbab AS et al.: Noninvasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma model. Blood 105, 420-425 (2005).
20. Arbab AS, Yocum GT, Wilson LB et al.: Comparison of transfection agents in forming complexes with ferumoxides, cell labeling efficiency, and cellular viability. Mol. Imaging 3, 24-32 (2004).
21. Smith SA, Mammen PP, Mitchell JH, Garry MG: Role of the exercise pressor reflex in rats with dilated cardiomyopathy. Circulation 108, 1126-1132 (2003).
22. Hierlihy AM, Seale P, Lobe CG, Rudnicki MA, Megeney LA: The post-natal heart contains a myocardial stem cell population. FEBS Lett. 530, 239-243 (2002).
23. Fukuhara S, Tomita S, Yamashiro S et al.: Direct cell-cell interaction of cardiomyocytes is key for bone marrow stromal cells to go into cardiac lineage in vitro. J. Thorac. Cardiovasc. Surg. 125, 1470-1480 (2003).
24. Messina E, De Angelis L, Frati G et al.: Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ. Res. 95, 911-921 (2004).
25. Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD: Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult routine heart. Circulation 105, 93-98 (2002).
26. Kawada H, Fujita J, Kinjo K et al.: Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction. Blood 104, 3581-3587 (2004).
27. Dell'Era P, Ronca R, Coco L, Nicoli S, Metra M, Presta M: Fibroblast growth factor receptor-1 is essential for in vitro cardiomyocyte development. Circ. Res. 93, 414-420 (2003).
28. Xia Y, McMillin JB, Lewis A et al.: Electrical stimulation of neonatal cardiac myocytes activates the NFAT3 and GATA4 pathways and up-regulates the adenylosuccinate synthetase 1 gene. J. Biel. Chem. 275, 1855-1863 (2000).
29. Xia Y, Buja LM, Scarpulla RC, McMillin JB: Electrical stimulation of neonatal cardiomyocytes results in the sequential activation of nuclear genes governing mitochondrial proliferation and differentiation. Proc. Natl Acad. Sci. USA 94, 11399-11404 (1997).
30. Guo XM, Zhao YS, Chang HX et al.: Creation of engineered cardiac tissue in vitro from mouse embryonic stem cells. Circulation 113, 2229-2237 (2006).
31. Menasche P, Hagege AA, Vilquin JT et al.: Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J. Am. Coll. Cardiol. 41, 1078-1083 (2003).
32. Menasche P, Hagege AA, Scorsin M et al.: Myoblast transplantation for heart failure. Lancet 357 279-280 (2001).
33. Haider H, Tan AC, Aziz S, Chachques JC, Sim EK: Myoblast transplantation for cardiac repair: a clinical perspective. Mol. Ther. 9, 14-23 (2004).
34. Dib N, McCarthy P, Campbell A et al.: Feasibility and safety of autologous myoblast transplantation in patients with ischemic cardiomyopathy. Cell Transplant 14, 11-19 (2005).
35. Herreros J, Prosper F, Perez A et al.: Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction. Eur. Heart J. 24, 2012-2020 (2003).
36. Smits PC, van Geuns RJ, Poldermans D et al.: Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up. J. Am. Coll. Cardiol. 42, 2063-2069 (2003).
37. Hamano K, Nishida M, Hirata K et al.: Local implantation of autologous bone marrow cells for therapeutic angiogenesis in patients with ischemic heart disease: clinical trial and preliminary results. Jpn Circ. J. 65, 845-847 (2001).
38. Li TS, Hamano K, Hirata K, Kobayashi T, Nishida M: The safety and feasibility of the local implantation of autologous bone marrow cells for ischemic heart disease. J. Card. Surg. 18(Suppl. 2), S69-S75 (2003).
39. + bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies. J. Thorac. Cardiovasc. Surg. 133, 717-725 (2007).
40. Stamm C, Westphal B, Kleine HD et al.: Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 361, 45-46 (2003).
41. Stamm C, Kleine HD, Westphal B et al.: CABG and bone marrow stem cell transplantation after myocardial infarction. Thorac, Cardiovasc. Surg. 52, 152-158 (2004).
42. Sadek H, Hannack B, Choe E et al.: Cardiogenic small molecules that enhance myocardial repair by stem cells. Proc. Natl Acad. Sci. USA 105, 6063-6068 (2008).